WEBINAR: Sirolimus-coated balloons, an appraisal on its potential advantages over paclitaxel

Watch this roundtable discussion if you want:

  • To learn and understand how and where to use a Sirolimus DCB in current practice
  • To see clinical evidence and results for the treatment of patients with Sirolimus DCB
  • To see the potential advantages of using the Sirolimus over Paclitaxel

Speakers: Antonio Colombo, Bernardo Cortese, Sandeep Basavarajaiah

 

EASTBOURNE registry finished the enrollment

EASTBOURNE registry finished the enrollment

EASTBOURNE

EASTBOURNE registry finished the enrollment a few days ago, with the terrific number of 2100 patients reached: this is the largest coronary DCB study ever done.

EASTBOURNE is a prospective registry and will describe the immediate and long term performance of the novel Magic Touch sirolimus-coated balloon for any coronary application. Interesting, this is an investigator-driven study without bias or inferences from the industry.

I want to congratulate each investigator of the study and Prof Antonio Colombo, co-chairman of the study.

Top enrollers are: L. Testa, T. Heang, A. Ielasi, I. Bossi, R. Latini, L. Yan, I. Sanchez, D. Milazzo, G. Caiazzo, F. Tomai, G. Di Palma, S. Benincasa, M. Montorfano, A. Nuruddin, G. Stefanini, G. Seresini, R. Singh, G. Cacucci.

You can find the interim analysis publication (600 pts @1y.) here: https://pubmed.ncbi.nlm.nih.gov/32740442/

Stay tuned!

__________

Bernardo Cortese, MD FESC